The interaction of these autoantibodies with csGRP78 triggers phosphoinositide 3-kinase (PI3K), protein kinase B (Akt) and mitogen-activated protein kinase (MAPK) signaling pathways, increasing cell survival during tumor growth and metastasis [24,25]. This evidence concerns the gene AKT1 and neoplasm.